CRE Review Report: Okuyemi 2007
Aug 13, 2010
CRE continues to review reports identified by FDA in the menthol proceeding.
CRE has previously completed analyses of several other studies and the results are published in this Forum.
Attached hereto is the CRE analysis of the following study:TPSAC Okuyemi 2007
Anonymous
August 15th, 2010 at 9:50 am #
Assuming your analysis is correct, how could the FDA possibly use this report?